Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Online Advisory Boards: Top 10 Frequently Asked Questions

It’s hard to imagine a time when some people in the life science industry had never attended a web meeting. Yet, that’s the reality we were living in just two...

Impetus Digital

Roche Basel Switzerland

Roche shares new positive Ocrevus data for MS patients

The CONSONANCE trial showed treatment with Ocrevus resulted in a majority of patients experiencing no disease progression

- PMLiVE

Novartis restructures organisation to support growth and innovation

The new operational structure will involve integrating pharmaceuticals and oncology business units into an Innovative Medicines business

Webcast: Demand Assessment

Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

Inizio

- PMLiVE

The changing face of the medical science liaison

By Carol Heggie (pictured left) and David Williams (pictured right)

- PMLiVE

Tackling health equity demands tackling diversity and inclusion

By Annalise Coady

- PMLiVE

Into the metaverse – could healthcare companies bravely go where few have already gone before?

By Eliza Hancock

- PMLiVE

Driving diversity, equity and inclusion in the workplace and in society

By Emma Greenwood

- PMLiVE

Paving the way for representation in clinical trials

By Lee-Ann Farrell (pictured left) and Dr Mohamed Lockhat (pictured right)

- PMLiVE

How marketers are balancing the changing trends in women’s health

We’ve reached a turning point in the way we view and provide healthcare to women. In the midst of discontent with the way that women are treated in healthcare and...

IGNIFI

- PMLiVE

Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis

In the UK, almost four million people are affected by osteoporosis, resulting in around 520,000 fragility fractures each year

- PMLiVE

ICR scientists create AI test to predict cancer drug combinations

The technique uses artificial intelligence (AI) to analyse large-scale protein data from tumour samples

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links